Evidence map›Paper›PMID 39966787›Full record

ArticleBMC geriatrics2025

Effect of remimazolam tosilate for injection (HR7056) versus sevoflurane on the incidence of postoperative delirium in older patients undergoing total hip arthroplasty: study protocol for a prospective, multicentre, two-arm, parallel-group, randomised controlled trial.

Lin-Yu Wang, Meng-Qing Zhang, Rui Sun, Liang Li, Dong-Liang Li

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lin-Yu WangDepartment of Anesthesiology, Shandong Provincial Hospital, Jinan, China.
Meng-Qing ZhangDepartment of Anesthesiology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan City, Shandong Province, China.
Rui SunDepartment of Anesthesiology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan City, Shandong Province, China.
Liang LiDepartment of Anesthesiology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan City, Shandong Province, China.
Dong-Liang LiDepartment of Anesthesiology, Qilu Hospital of Shandong University, 107 Wenhua West Road, Lixia District, Jinan City, Shandong Province, China. ldl@sdu.edu.cn.

Funding

Medical Empowerment Public Welfare Special Fund of the Red Cross Foundation of China CRCF-YXFN-202201035Natural Science Foundation of Shandong Province ZR2021MH102
6 · The paper itself

Abstract

introductionPostoperative delirium (POD) is a common postoperative complication and is associated with numerous adverse outcomes. Advanced age and hip surgery are high risk factors for POD. Both remimazolam tosilate for injection and sevoflurane can be used as sedatives for the maintenance of general anesthesia, but the comparison of their impacts on the incidence of POD has not been reported. This study aims to compare the effect of remimazolam tosilate vernus sevoflurane on the incidence of POD in older patients undergoing total hip arthroplasty. METHODS AND ANALYSIS: This is a two-arm, parallel, prospective, multicenter, randomized controlled trial. A total of 456 older patients at six clinical trial centers in China will be randomly assigned in a 1:1 ratio to receive general anesthesia with remimazolam tosilate or sevoflurane as sedative. The primary outcome measure is the prevalence of POD during the first 4 postoperative days. Secondary outcomes include cognitive function [Mini-Mental State Examination (MMSE)], perioperative pain degree [Visual Analogue Scale (VAS)], postoperative nausea and vomiting (PONV) within 4 days after surgery, recovery time after drug withdrawal, the amount of vasoactive drugs used during operation, length of hospital stay, and in-hospital complications. ETHICS AND DISSEMINATION: The Research Ethics Committee of Qilu Hospital of Shandong University has approved the study protocol (REF: KYLL-202206-25), which is applicable to all research centers. Participant recruitment begins in August 2022. Written informed consent will be obtained from each patient before randomization. The findings will be published in an international peer-reviewed medical journal.

trial registrationThe trial has been registered at the Chinese Clinical Trial Registry: ChiCTR2200062455; date of registration: 2022-08-08.

Indexed as

Arthroplasty, Replacement, HipBenzodiazepinesDeliriumHypnotics and SedativesPostoperative ComplicationsSevofluraneAgedAnesthetics, InhalationChinaFemaleHumansIncidenceMaleMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as TopicAnesthetics, InhalationBenzodiazepinesHypnotics and SedativesremimazolamSevofluraneHip arthroplastyOlder patientsPostoperative deliriumRemimazolam tosilateSevoflurane

Identifiers

PMID39966787
PMCPMC11834618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.